We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information leaflet and sticker for the COVID-19 autumn vaccination programme.
Information and promotional resources to support the 2024 to 2025 annual flu vaccination programme.
Information on COVID-19, including guidance on the assessment and management of suspected UK cases.
This plan outlines UKHSA’s goals and strategic priorities for the next 3 years to protect the nation’s health from current and future threats.
Guidelines for managing close community contacts of cases of invasive group A streptococcal (iGAS) disease, including flow diagrams.
The characteristics, management and surveillance of shingles (herpes zoster).
UKHSA urges overseas travellers, including Hajj pilgrims, to check well in advance to ensure they are up to date and have all necessary vaccinations
Description of scarlet fever, potential complications of the disease and advice on who's most at risk and how to prevent the spread.
Historical vaccine development and introduction of vaccines in the UK.
Monthly counts of Escherichia coli (E.coli) bacteraemia by organisation and location of onset (from April 2019).
The characteristics, symptoms and epidemiology of parvovirus B19 (also known as slapped cheek syndrome, fifth disease, or erythma infectiosum).
Information and resources on the UK’s plans to see antimicrobial resistance contained and controlled by 2040.
RIPL specialises in the diagnosis and management of unusual or hazardous infectious diseases present in the UK or imported into the country.
Funding of £85 million will be announced at a global event to support the international community in tackling the growing threat of antimicrobial resistance.
First published during the 2022 to 2024 Sunak Conservative government
Documents relating to the Bacillus Calmette–Guérin (BCG) vaccination programme.
The annual flu letter describes the national flu immunisation programme and outlines which groups are eligible for flu vaccination.
Weekly data from UK laboratories on the number of cases of notifiable bacteria and viruses.
The epidemiology, symptoms, diagnosis and management of monkeypox virus infections.
PGD template to support the provision of hepatitis A vaccine to individuals pre- and post-exposure to hepatitis A.
The characteristics, diagnosis, management, surveillance and epidemiology of Clostridioides difficile (C. difficile).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).